Capstone (CAPS) vs Processa Pharmaceuticals (PCSA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Processa Pharmaceuticals is the larger company by market cap ($3.8 million vs $3.7 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CAPS | PCSA |
|---|---|---|
| Share price | $0.1409 | $1.35 |
| Market cap | $3.72M | $3.77M |
| 1-day change | +0.57% | -4.93% |
| EPS (TTM) | $-3.32 | $-4.33 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $1.36 | $11.08 |
| 52-week low | $0.13 | $1.32 |
| Distance from 52-week high | -89.64% | -87.81% |
| Analyst consensus | none | — |
| Avg. price target upside | +2029.17% | — |
| Average volume | 4.35M | 224.03K |
| Shares outstanding | 26.38M | 2.79M |
| Employees | 93 | 12 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Capstone
CAPS stock →Capstone Holding Corp., through its subsidiaries, engages in the distribution and installation of building products in the United States and Canada. It operates in two segments, TotalStone and Carolina Stone.
Health Care · Biotechnology: Pharmaceutical Preparations · 93 employees
About Processa Pharmaceuticals
PCSA stock →Processa Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops cancer therapy drugs to improve the safety and efficacy of cancer treatment in the United States. The company's drugs are modifications of existing FDA-approved oncology drugs, resulting in an alteration of the metabolism and/or distribution of drugs while maintaining the existing mechanisms for killing cancer cells.
Health Care · Biotechnology: Pharmaceutical Preparations · 12 employees
CAPS vs PCSA FAQ
Which is bigger, Capstone or Processa Pharmaceuticals?
Processa Pharmaceuticals (PCSA) is larger, with a market capitalization of $3.77M compared with $3.72M for Capstone (CAPS).
Are Capstone and Processa Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.